FDA hits lab with warning letter for using one login for all staff
A US contract testing laboratory has received a FDA warning letter for allowing all its employees to use the same username and password.
A US contract testing laboratory has received a FDA warning letter for allowing all its employees to use the same username and password.
Celerion and Ricera Biosciences have launched a new joint venture to provide a cost-cutting one-stop-shop solution for companies developing and commercialising biosimilars.